JoVE Logo

Sign In

25.7 : Insulin: Biosynthesis, Chemistry, and Preparation

The endoplasmic reticulum (ER) of pancreatic β-cells synthesizes preproinsulin, which consists of a signal peptide, A and B chains, and a C-peptide. Preproinsulin is then cleaved and folded into proinsulin, which translocates to the Golgi apparatus for sorting and packaging into secretory granules. In these granules, enzymatic clipping generates insulin and C-peptide.

Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment primarily uses recombinant human insulin in regular or neutral protamine hagedorn (NPH) formulations. Both rapid-acting and long-acting analogs of insulin, created by modifying the amino acid sequences or insulin structure, are available.

For instance, insulin lispro, created by reversing the 28th and 29th amino acids in the B chain, promotes rapid absorption by forming monomers. Insulin glargine, on the other hand, replaces asparagine at the 21st position with glycine and extends the B chain by adding two arginine. It precipitates at pH 7.4 upon injection, resulting in slower absorption and extended action. These modifications enhance diabetes management by tailoring insulin action to patient needs.

Tags

InsulinBiosynthesisPreproinsulinProinsulinEndoplasmic ReticulumPancreatic Beta CellsGolgi ApparatusDiabetes TreatmentRecombinant Human InsulinNPH FormulationsRapid acting AnalogsLong acting AnalogsInsulin LisproInsulin GlargineAmino Acid Modifications

From Chapter 25:

article

Now Playing

25.7 : Insulin: Biosynthesis, Chemistry, and Preparation

Insulin and Hypoglycemic Drugs

329 Views

article

25.1 : Glucose Homeostasis: Regulation of Blood Glucose

Insulin and Hypoglycemic Drugs

1.3K Views

article

25.2 : Glucose Homeostasis: Pancreatic Islets and Insulin Secretion

Insulin and Hypoglycemic Drugs

1.0K Views

article

25.3 : Insulin: The Receptor and Signaling Pathways

Insulin and Hypoglycemic Drugs

1.1K Views

article

25.4 : Pathophysiology of Diabetes

Insulin and Hypoglycemic Drugs

837 Views

article

25.5 : Diabetes: Symptoms, Diagnosis, and Complications

Insulin and Hypoglycemic Drugs

494 Views

article

25.6 : Diabetes: Management and Pharmacotherapy

Insulin and Hypoglycemic Drugs

216 Views

article

25.8 : Insulin Formulations: Types and Delivery

Insulin and Hypoglycemic Drugs

147 Views

article

25.9 : Insulin: Dosing Regimen and Adverse Effects

Insulin and Hypoglycemic Drugs

134 Views

article

25.10 : Oral Hypoglycemic Agents: Sulfonylureas

Insulin and Hypoglycemic Drugs

172 Views

article

25.11 : Oral Hypoglycemic Agents: Biguanides and Glitazones

Insulin and Hypoglycemic Drugs

148 Views

article

25.12 : Oral Hypoglycemic Agents: Glinides

Insulin and Hypoglycemic Drugs

120 Views

article

25.13 : Oral Hypoglycemic Agents: α-Glucosidase Inhibitors

Insulin and Hypoglycemic Drugs

139 Views

article

25.14 : Glucagon-like Receptor Agonists

Insulin and Hypoglycemic Drugs

280 Views

article

25.15 : Dipeptidyl Peptidase 4 Inhibitors

Insulin and Hypoglycemic Drugs

148 Views

See More

JoVE Logo

Privacy

Terms of Use

Policies

Research

Education

ABOUT JoVE

Copyright © 2025 MyJoVE Corporation. All rights reserved